VINORELBINE for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 61 adverse event reports in the FDA FAERS database where VINORELBINE was used for Off label use.
Most Reported Side Effects for VINORELBINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 644 | 12.4% | 139 | 258 |
| Malignant neoplasm progression | 624 | 12.1% | 107 | 110 |
| Disease progression | 526 | 10.2% | 135 | 95 |
| Neutropenia | 517 | 10.0% | 75 | 175 |
| Nausea | 504 | 9.7% | 77 | 227 |
| Drug ineffective | 391 | 7.6% | 78 | 84 |
| Fatigue | 373 | 7.2% | 76 | 162 |
| Diarrhoea | 371 | 7.2% | 58 | 174 |
| Vomiting | 342 | 6.6% | 44 | 173 |
| Anaemia | 335 | 6.5% | 56 | 123 |
| Thrombocytopenia | 308 | 6.0% | 72 | 92 |
| Febrile neutropenia | 305 | 5.9% | 58 | 194 |
| Pyrexia | 296 | 5.7% | 57 | 165 |
| Dyspnoea | 263 | 5.1% | 57 | 124 |
| Asthenia | 250 | 4.8% | 29 | 96 |
Other Indications for VINORELBINE
Breast cancer (641)
Breast cancer metastatic (623)
Product used for unknown indication (604)
Hodgkin's disease (333)
Her2 positive breast cancer (309)
Non-small cell lung cancer (254)
Lung adenocarcinoma (197)
Lung neoplasm malignant (160)
Diffuse large b-cell lymphoma (155)
Chemotherapy (148)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)